Malcisbo closes seed financing round

In September the ETH Spinoff Malcisbo Ltd. has successfully closed its seed financing round. The initial target of CHF 2.4 Mio. was substantially exceeded. Private investors, Business Angels, Zürcher Kantonalbank Startup Finance and Redalpine Venture Partners AG have invested in total a sum of CHF 3.6 Mio in the company. In parallel the company was granted a substantial research contribution by CTI.

The technology of Malcisbo allows developing a wide variety of vaccines against parasites and bacteria which infect both humans and animals.